Mifentidine

Drug Profile

Mifentidine

Alternative Names: DA 4577

Latest Information Update: 17 Oct 2003

Price : $50

At a glance

  • Originator Boehringer Ingelheim
  • Class Antihistamines; Antiulcers
  • Mechanism of Action Histamine H2 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Duodenal ulcer

Most Recent Events

  • 17 Nov 1998 Discontinued - Phase-II for Duodenal ulcers in Germany
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top